D. Vallois, Mélanie Juilland, Kalliopi Ioannidou, F. Lemonnier, E. Missiaglia, Bettina Bisig, Margot Thome, L. D. de Leval
2025.2.28Blood Advances
tlooto Summary
RHOA G17V enhances CD3/CD28-induced NFAT transcriptional activity by binding p300 and enhancing its histone acetyltransferase activity, and has epigenetics effects.
Abstract
Several algorithms have been described in the literature for protein identification by searching a sequence database using mass spectrometry data. In some approaches, the experimental data are peptide molecular weights from the digestion of a protein by an enzyme. Other approaches use tandem mass spectrometry (MS/MS) data from one or more peptides. Still others combine mass data with amino acid sequence data. We present results from a new computer program, Mascot, which integrates all three types of search. The scoring algorithm is probability based, which has a number of advantages: (i) A simple rule can be used to judge whether a result is significant or not. This is particularly useful in guarding against false positives. (ii) Scores can be com pared with those from other types of search, such as sequence homology. (iii) Search parameters can be readily optimised by iteration. The strengths and limitations of probability‐based scoring are discussed, particularly in the context of high throughput, fully automated protein identification.
Citation format
VALLOIS, D., et al. Binding of RHOA G17V to p300 enhances its HAT activity: A new mechanism of epigenetic deregulation in TFH lymphoma. Blood Advances, 2025, 9: 3031–3043.